|
![]() |
|||
|
||||
OverviewThis volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations. HIV-1 inhibitor resistance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce viral resistance, and alter the state of viral latency are presented. Experts at the forefront of HIV-1 research provide overviews of approaches from the fields of virology, chemical biology and structural biology for obtaining small molecule inhibitors that target viral regulatory and structural components at multiple points in the viral lifecycle. The individual chapters will appeal to scientists and clinicians alike. Full Product DetailsAuthor: Bruce Torbett , David S Goodsell (Department of Molecular Biology, The Scripps Research Institute, La Jolla, California, USA) , Douglas RichmanPublisher: Springer International Publishing Imprint: Springer International Publishing ISBN: 9783319185187ISBN 10: 3319185187 Pages: 257 Publication Date: 01 January 2015 Audience: General/trade , General Format: Electronic book text Publisher's Status: Active Availability: Available To Order ![]() We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |